Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Tebapivat by Agios Pharmaceuticals for Myelodysplastic Syndrome: Likelihood of Approval
Tebapivat is under clinical development by Agios Pharmaceuticals and currently in Phase II for Myelodysplastic Syndrome. According to GlobalData, Phase...
Tebapivat by Agios Pharmaceuticals for Sickle Cell Disease: Likelihood of Approval
Tebapivat is under clinical development by Agios Pharmaceuticals and currently in Phase I for Sickle Cell Disease. According to GlobalData,...
Mitapivat sulfate by Agios Pharmaceuticals for Beta Thalassaemia: Likelihood of Approval
Mitapivat sulfate is under clinical development by Agios Pharmaceuticals and currently in Phase III for Beta Thalassaemia. According to GlobalData,...
Mitapivat sulfate by Agios Pharmaceuticals for Alpha Thalassaemia: Likelihood of Approval
Mitapivat sulfate is under clinical development by Agios Pharmaceuticals and currently in Phase III for Alpha Thalassaemia. According to GlobalData,...
AG-181 by Agios Pharmaceuticals for Phenylketonuria (PKU): Likelihood of Approval
AG-181 is under clinical development by Agios Pharmaceuticals and currently in Phase I for Phenylketonuria (PKU). According to GlobalData, Phase...